Significant improvement in islet yield and survival with modified ET-Kyoto solution: ET-Kyoto/neutrophil elastase inhibitor

Tomohiko Machida, Masahiro Tanemura, Yoshiaki Ohmura, Tsukasa Tanida, Hiroshi Wada, Shogo Kobayashi, Shigeru Marubashi, Hidetoshi Eguchi, Toshinori Ito, Hiroaki Nagano, Masaki Mori, Yuichiro Doki, Yoshiki Sawa

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Although islet transplantation can achieve insulin independence in patients with type 1 diabetes, sufficient number of islets derived from two or more donors is usually required to achieve normoglycemia. Activated neutrophils and neutrophil elastase (NE), which is released from these neutrophils, can directly cause injury in islet grafts. We hypothesized that inhibition of NE improves islet isolation and islet allograft survival. We tested our hypothesis by examining the effects of modified ET-Kyoto solution supplemented with sivelestat, a NE inhibitor (S-Kyoto solution), on islet yield and viability in islet isolation and the effect of intraperitoneally injected sivelestat on islet graft survival in a mouse allotransplant model. NE and proinflammatory cytokines such as tumor necrosis factor (TNF)-α and interleukin (IL)-6 increased markedly at the end of warm digestion during islet isolation and exhibited direct cytotoxic activity against the islets causing their apoptosis. The use of S-Kyoto solution significantly improved islet yield and viability. Furthermore, treatment with sivelestat resulted in significant prolongation of islet allograft survival in recipient mice. Furthermore, serum levels of IL-6 and TNF-α at 1 and 2 weeks posttransplantation were significantly higher in islet recipients than before transplantation. Our results indicated that NE released from activated neutrophils negatively affects islet survival and that its suppression both in vitro and in vivo improved islet yield and prolonged islet graft survival. The results suggest that inhibition of NE activity could be potentially useful in islet transplantation for patients with type 1 diabetes mellitus.

Original languageEnglish
Pages (from-to)159-173
Number of pages15
JournalCell Transplantation
Volume22
Issue number1
DOIs
Publication statusPublished - Feb 1 2013
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Significant improvement in islet yield and survival with modified ET-Kyoto solution: ET-Kyoto/neutrophil elastase inhibitor'. Together they form a unique fingerprint.

  • Cite this

    Machida, T., Tanemura, M., Ohmura, Y., Tanida, T., Wada, H., Kobayashi, S., Marubashi, S., Eguchi, H., Ito, T., Nagano, H., Mori, M., Doki, Y., & Sawa, Y. (2013). Significant improvement in islet yield and survival with modified ET-Kyoto solution: ET-Kyoto/neutrophil elastase inhibitor. Cell Transplantation, 22(1), 159-173. https://doi.org/10.3727/096368912X637028